People with a history of cognitively stimulating occupations during their 30s, 40s, 50s, and 60s had a lower risk of mild cognitive impairment and dementia after age 70.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
The source of essential tremor—involuntary, rhythmic trembling—has been elusive, but a new study points to abnormal electrical activity in the base of the brain.
Researchers had high hopes for Alzheimer’s drugs that clear amyloid from the brain, but none of the drugs have slowed the disease. Columbia’s Scott Small says he has new reasons to be optimistic.
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.
Survivors of cardiac arrest are more likely to experience further heart trouble if they have symptoms of PTSD, according to a new study from researchers at Columbia University Irving Medical Center.